Fennec Pharmaceuticals Inc (FENC): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 17,667 US Dollar | 4 | 2 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 35.067.159 | 1,61 | 3,54 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Fennec Pharmaceuticals Inc
Mitarbeiter 35
Handelsplatz NASDAQ
Ticker Symbol FENC
IPO Datum 2001-06-05
Adresse 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
Webseite https://www.fennecpharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Jeffrey S. Hackman | CEO & Director |
| 2 | Mr. Robert C. Andrade | Chief Financial Officer |
| 3 | Dr. Pierre S. Sayad M.S., Ph.D. | Chief Medical Officer |
| 4 | Mr. Terry Evans | Chief Commercial Officer |
| 5 | Ms. Christiana Cioffi M.B.A. | Chief Strategy Officer |
| 6 | Mr. Mark Gowland | Controller |
| 7 | Mr. Lei Fang | President of Pharstat Inc |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Rosalind Advisors, Inc. | 9,09% | 34,65 Mio. USD |
| 2 | AIGH Capital Management, LLC | 7,09% | 27,02 Mio. USD |
| 3 | Solas Capital Management LLC | 5,39% | 20,54 Mio. USD |
| 4 | BlackRock Inc | 4,93% | 18,77 Mio. USD |
| 5 | Awm Investment Company Inc | 3,31% | 12,61 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 2,39% | 9,12 Mio. USD |
| 7 | Prospect Capital Advisors, LLC | 1,42% | 5,41 Mio. USD |
| 8 | State Street Corp | 1,21% | 4,63 Mio. USD |
| 9 | Geode Capital Management, LLC | 1,15% | 4,38 Mio. USD |
| 10 | Jane Street Group LLC | 0,67% | 2,54 Mio. USD |
| 11 | Potomac Capital Management, Inc. | 0,64% | 2,44 Mio. USD |
| 12 | Morgan Stanley - Brokerage Accounts | 0,63% | 2,41 Mio. USD |
| 13 | Vanguard Portfolio Management, LLC | 0,57% | 2,17 Mio. USD |
| 14 | Northern Trust Corp | 0,48% | 1,83 Mio. USD |
| 15 | Marshall Wace Asset Management Ltd | 0,40% | 1,51 Mio. USD |
| 16 | Renaissance Technologies Corp | 0,38% | 1,46 Mio. USD |
| 17 | Nuveen, LLC | 0,37% | 1,43 Mio. USD |
| 18 | Trexquant Investment LP | 0,34% | 1,30 Mio. USD |
| 19 | CenterBook Partners LP | 0,34% | 1,29 Mio. USD |
| 20 | Lion Point Capital, LP | 0,32% | 1,22 Mio. USD |